China Merchants CSI Biotechnology Theme ETF Stock (159849.SZ) Real-time Quotes - Financial Data - Analyst Ratings

Company Encyclopedia

China Merchants CSI Biotechnology Theme ETF

159849.SZ

Shareholder

Ownership	%Owned	Share Chg	Report Date
No Data

News

"Domestic Medical Device Leader" Listed for the Third Time: Mindray Aims for Internationalization

Not for financing

Wallstreetcn·Yesterday at 17:41

300760

-1.88%

Wallstreetcn·Yesterday at 17:41

300760

-1.88%

Under the pressure of the betting agreement, Genuine Biotech makes its third attempt at the Hong Kong Stock Exchange

Genuine Biotech Limited is facing a significant decline in revenue and tight cash flow due to the waning market demand for its core product Azvudine and the termination of its cooperation with FOSUN PHARMA, under pressure from a listing bet agreement. The company applied for a listing on the Hong Kong Stock Exchange for the third time in November 2025, after two previous applications were unsuccessful. Azvudine needs to complete confirmatory clinical research before 2026

BambooWorks·Yesterday at 09:00